Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers

International Journal of Pharmaceutics

Volumn 359, Issue 1-2, 2008, Pages 272-279

  Shehata, Tamer ^a   Ogawara, Ken ichi ^a   Higaki, Kazutaka ^a   Kimura, Toshikiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Dysopsonins; Opsonins; PEG liposome; Pharmacokinetics; Polyvinyl alcohol

Indexed keywords

ALBUMIN; CHOLESTEROL; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; MACROGOL; OPSONIN; PHOSPHATIDYLCHOLINE; PLASMA PROTEIN; POLYVINYL ALCOHOL;

ADSORPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG DISTRIBUTION; ENDOCYTOSIS; LIQUID CHROMATOGRAPHY; LIVER; LIVER CLEARANCE; LIVER PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SYSTEMIC CIRCULATION; TANDEM MASS SPECTROMETRY;

ADSORPTION; ANIMALS; AREA UNDER CURVE; BLOOD PROTEINS; CHOLESTEROL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLUORESCEINS; LIPOSOMES; LIVER; MALE; OPSONIN PROTEINS; PHOSPHATIDYLCHOLINES; POLYETHYLENE GLYCOLS; POLYVINYL ALCOHOL; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 44749084983     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.04.004     Document Type: Article

References (45)

1. Absolom D.R. Opsonins and dysopsonins: an overview. Methods Enzymol. 132 (1986) 281-318
2. Allen T.M., and Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223 (1987) 42-46
3. Allen T.M., and Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta 1068 (1991) 133-141
4. Allen T.M., Hansen C., Martin F., Redemann C., and Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066 (1991) 29-36
5. Awasthi V.D., Garcia D., Goins B.A., and Phillips W.T. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int. J. Pharm. 253 (2003) 121-132
6. Banerjee R. Liposomes: applications in medicine. J. Biomater. Appl. 16 (2001) 3-21
7. Bisgaier C.L., Siebenkas M.V., and Williams K.J. Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J. Biol. Chem. 264 (1989) 862-866
8. Bonte F., and Juliano R.L. Interactions of liposomes with serum proteins. Chem. Phys. Lipids 40 (1986) 359-372
9. Chonn A., Semple S.C., and Cullis P.R. Association of blood proteins with large unilamellar liposomes in vivo: relation to circulation lifetimes. J. Biol. Chem. 267 (1992) 18759-18765
10. Furumoto K., Ogawara K., Nagayama S., Takakura Y., Hashida M., Higaki K., and Kimura T. Important role of serum proteins associated on the surface of particles in their hepatic disposition. J. Control. Rel. 83 (2002) 89-96
11. Furumoto K., Yokoe J., Ogawara K., Amano S., Takaguchi M., Higaki K., Kai T., and Kimura T. Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. Int. J. Pharm. 329 (2007) 110-116
12. Gabizon A., and Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6949-6953
13. Huong T.M., Ishida T., Harashima H., and Kiwada H. Species difference in correlation between in vivo/in vitro liposome-complement interactions. Biol. Pharm. Bull. 24 (2001) 439-441
14. Ishida T., Harashima H., and Kiwada H. Liposome clearance. Biosci. Rep. 22 (2002) 197-224
15. Ishida T., Ichihara M., Wang X., Yamamoto K., Kimura J., Majima E., and Kiwada H. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J. Control. Rel. 112 (2006) 15-25
16. Johnstone S.A., Masin D., Mayer L., and Bally M.B. Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly (ethylene glycol) liposomes by mouse macrophages. Biochim. Biophys. Acta 1513 (2001) 25-37
17. Levchenko T.S., Rammohan R., Lukyanov A.N., Whiteman K.R., and Torchilin V.P. Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. Int. J. Pharm. 240 (2002) 95-102
18. Lian T., and Ho R. Trends and development in liposome drug delivery systems. J. Pharm. Sci. 90 (2001) 667-680
19. Liu D., Liu F., and Song Y.K. Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Biochim. Biophys. Acta 1235 (1995) 140-146
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 (1951) 265-275
21. Maruyama K., Ishida O., Takizawa T., and Moribe K. Possibility of active targeting to tumor tissues with liposomes. Adv. Drug Deliv. Rev. 40 (1999) 89-102
22. Moghimi S.M., and Davis S.S. Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit. Rev. Ther. Drug Carrier Syst. 11 (1994) 31-59
23. Moghimi S.M., Hamad I., Bunger R., Andresen T.L., Jorgensen K., Hunter A.C., Baranji L., Rosivall L., and Szebeni J. Activation of the human complement system by cholesterol-rich and PEGylated liposomes-modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels. J. Liposome Res. 16 (2006) 167-174
24. Murao A., Nishikawa M., Managit C., Wong J., Kawakami S., Yamashita F., and Hashida M. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition. Pharm. Res. 19 (2002) 1808-1814
25. Needham D., Stoicheva N., and Zhelev D.V. Exchange of monooleoylphosphatidylcholine as monomer and micelle with membranes containing poly(ethylene glycol)-lipid. Biophys. J. 73 (1997) 2615-2629
26. Nicholas A.R., Scott M.J., Kennedy N.I., and Jones M.N. Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. Biochim. Biophys. Acta 1463 (2000) 167-178
27. Ogawara K., Furumoto K., Nagayama S., Minato K., Higaki K., Kai T., and Kimura T. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J. Control. Rel. 100 (2004) 451-455
28. Ogawara K., Yoshida M., Takakura Y., Hashida M., Higaki K., and Kimura T. Interaction of polystyrene microspheres with liver cells: role of membrane receptors and serum proteins. Biochim. Biophys. Acta 1472 (1999) 165-172
29. Parr M.J., Ansell S.M., Choi L.S., and Cullis P.R. Factors influencing the retention and chemical stability of poly(ethyleneglycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim. Biophys. Acta 1195 (1994) 21-30
30. Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., and Fidler I.J. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res. 42 (1982) 1412-1422
31. Price M.E., Cornelius R.M., and Brash J.L. Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma. Biochim. Biophys. Acta 1512 (2001) 191-205
32. Rossi J.D., and Wallace B.A. Binding of fibronectin to phospholipid vesicles. J. Biol. Chem. 258 (1983) 3327-3331
33. Sadzuka Y., Nakade A., Hirama R., Miyagishima A., Nozawa Y., Hirota S., and Sonobe T. Effect of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int. J. Pharm. 238 (2002) 171-180
34. Senior J.H. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3 (1987) 123-193
35. Shimada K., Miyagishima A., Sadzuka Y., Nozawa Y., Mochizuki Y., Ohshima H., and Hirota S. Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes. J. Drug Target 3 (1995) 283-289
36. Sihorkar V., and Vyas S.P. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J. Pharm. Pharm. Sci. 4 (2001) 138-158
37. 3H] cholesteryl oleyl ether in cultured fibroblasts and intact rat. FEBS Lett. 111 (1980) 104-106
38. Takeuchi H., Kojima H., Yamamoto H., and Kawashima Y. Polymer coating of liposomes with a modified polyvinyl alcohol and their systemic circulation and RES uptake in rats. J. Control. Rel. 68 (2000) 195-205
39. Takeuchi H., Kojima H., Yamamoto H., and Kawashima Y. Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. J. Control. Rel. 75 (2001) 83-91
40. Takeuchi H., Yamamoto H., Toyoda T., Toyobuku H., Hino T., and Kawashima Y. Physical stability of size controlled small unilamellar liposomes coated with a modified polyvinyl alcohol. Int. J. Pharm. 164 (1998) 103-111
41. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160
42. Tsujimoto M., Inoue K., and Nojima S. Reactivity of human C-reactive protein with positively charged liposomes. J. Biochem. (Tokyo) 90 (1981) 1507-1514
43. Van Oss C.J., Gillman C.F., Bronson P.M., and Border J.R. Phagocytosis-inhibiting properties of human serum alpha-1 acid glycoprotein. Immunol. Commun. 3 (1974) 321-328
44. Yamaoka K., Nakagawa T., and Uno T. Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6 (1978) 547-558
45. Zeisig R., Shimada K., Hirota S., and Arndt D. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Biochim. Biophys. Acta 1285 (1996) 237-245